Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in JAMA

Retrieve available abstracts of 226 articles:
HTML format

Single Articles

    February 2024
    Africa's First Routine Malaria Vaccination Campaign Begins.
    JAMA. 2024 Feb 7. doi: 10.1001/jama.2024.0170.

  2. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    PubMed     Abstract available

  3. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    PubMed     Abstract available

    January 2024
    Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.

    CDC Warns of Low Vaccination Rates Amid Spike in Respiratory Diseases.
    JAMA. 2024 Jan 17. doi: 10.1001/jama.2023.27428.

  6. MARKS P, Califf R
    Is Vaccination Approaching a Dangerous Tipping Point?
    JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.

    High-Dose Flu Vaccine May Be More Effective for Midlife Adults.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26114.

    December 2023
  8. RUBIN R
    Despite Safe and Effective Vaccine, Measles Cases and Deaths Increased Worldwide From 2021 to 2022.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25527.

  9. RUBIN R
    Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.

    November 2023
  10. HARRIS E
    FDA Approves First Chikungunya Vaccine.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23505.

  11. HARRIS E
    Measles Outbreaks Grow Amid Declining Vaccination Rates.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23511.

  12. HARRIS E
    Live-Virus Shingles Vaccine Provided Some Long-Term Protection.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23507.

  13. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
    JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
    PubMed     Abstract available

  14. HARRIS E
    Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.

  15. HARRIS E
    FDA Will Evaluate First Self-Administered FluMist Vaccine.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870.

  16. MALANI P
    Highlights From IDWeek 2023-New Vaccines, Artificial Intelligence, and Antimicrobial Resistance.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.19291.

    October 2023
  17. HARRIS E
    Vaccination Hesitancy Increasing Among Pregnant Women.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19800.

  18. HARRIS E
    Trial Launches of New HIV Vaccine Candidate With CMV Vector.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19203.

  19. DELAMATER PL, Buttenheim AM, Salmon DA, Schwartz JL, et al
    Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy.
    JAMA. 2023 Oct 2:e2316995. doi: 10.1001/jama.2023.16995.

    September 2023
  20. HARRIS E
    NIH Launches Phase 1 Trial of Broader "Universal" Flu Vaccine.
    JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18741.

  21. HARRIS E
    Southern Hemisphere Outcomes Support Flu Vaccine Effectiveness.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17822.

  22. RUBIN R
    Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
    JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.

  23. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
    Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.

  24. HARRIS E
    HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.

  25. HARRIS E
    CDC Recommends RSV Immunization for Infants.
    JAMA. 2023;330:797.

    August 2023
  26. HARRIS E
    FDA Approves Maternal RSV Vaccine.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106.

    July 2023
  27. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.

  28. GOSTIN LO, Reiss D, Mello MM
    Vaccination Mandates-An Old Public Health Tool Faces New Challenges.
    JAMA. 2023 Jul 24. doi: 10.1001/jama.2023.11059.

  29. HARRIS E
    First Ever Malaria Vaccine to Be Distributed in Africa.
    JAMA. 2023 Jul 19. doi: 10.1001/jama.2023.12549.

  30. HARRIS E
    CDC: RSV Vaccine Recommended for Older People.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12537.

  31. RUBIN R
    This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.

    June 2023
  32. HARRIS E
    Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10738.

  33. Public Health: An Interesting Parliamentary Debate on Vaccination.
    JAMA. 2023;329:2099.

  34. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
    BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
    JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.

  35. HARRIS E
    Hybrid COVID-19 Immunity Common by Fall of 2022.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.

  36. DESAI AN, Malani PN
    JYNNEOS Vaccine for Mpox.
    JAMA. 2023;329:1995.

    May 2023
  37. HARRIS E
    COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.

  38. HARRIS E
    FDA Clears RSV Vaccine for Adults Aged 60 Years or Older.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8657.

  39. DENG L, Lopez LK, Glover C, Cashman P, et al
    Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox.
    JAMA. 2023 May 5. doi: 10.1001/jama.2023.7683.

  40. HARRIS E
    BCG Vaccine Not Effective Against COVID-19.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.

    April 2023
  41. HARRIS E
    FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.

  42. HARRIS E
    How Parents' Views Are Tied to Children's COVID-19 Vaccination.
    JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.

  43. HARRIS E
    RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6254.

  44. HARRIS E
    Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.

  45. AMMIRATI E, Moslehi JJ
    Diagnosis and Treatment of Acute Myocarditis: A Review.
    JAMA. 2023;329:1098-1113.
    PubMed     Abstract available

    March 2023
  46. ZHOU YB
    Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine.
    JAMA. 2023;329:1031.

  47. HAZRA A, Schneider JA
    Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine-Reply.
    JAMA. 2023;329:1032.

  48. HARRIS E
    Cost-effective Global Strep B Vaccination Would Prevent Infant Deaths.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4005.

  49. SURAN M
    Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession-Even If It Doesn't Become Law.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3401.

  50. SO S, Terrault N, Conners EE
    Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.2806.

    February 2023
  51. FLANNERY DD, Zevallos Barboza A, Wade KC, Pfeifer MR, et al
    Measles Serostatus Among Parturient Patients at 2 Philadelphia Hospitals in 2021.
    JAMA. 2023;329:682-684.

  52. HARRIS E
    COVID-19 Vaccination During Pregnancy Protected Infants.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.

  53. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
    PubMed     Abstract available

  54. HARRIS E
    Marburg Vaccine Safe, Immunogenic in Phase 1 Trial.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1343.

  55. RUBIN R
    Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.

  56. CHU WM, Wang CY, Wei JC
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2023;329:426.

  57. HUH K, Kim YE, Jung J
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
    JAMA. 2023;329:426-427.

  58. SURAN M
    New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2022.23242.

  59. LARKIN H
    Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.

    January 2023
  60. ROLFES MA, Talbot HK, McLean HQ, Stockwell MS, et al
    Household Transmission of Influenza A Viruses in 2021-2022.
    JAMA. 2023 Jan 26. doi: 10.1001/jama.2023.0064.
    PubMed     Abstract available

  61. RUBIN R
    Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0050.

    Ebola Vaccines Safe and Immunogenic in 2 Trials.
    JAMA. 2023;329:278-279.

    Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants.
    JAMA. 2023;329:279.

  64. MCCARTHY MW, Naggie S, Boulware DR, Lindsell CJ, et al
    Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.24100.
    PubMed     Abstract available

  65. LARKIN H, Larkin H
    Twenty-Strain "Universal" mRNA Flu Vaccine Effective in Animal Studies.
    JAMA. 2023;329:114.

  66. LARKIN H
    Whole-Sporozoite Malaria Vaccine Candidate Shows Real-world Promise.
    JAMA. 2023;329:115.

    December 2022
    Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.
    JAMA. 2022;328:2388.

  68. LARKIN H
    WHO: Vaccine Market Report Highlights Inequitable Global Distribution.
    JAMA. 2022;328:2294.

  69. WALTER K, Malani PN
    What Is Measles?
    JAMA. 2022;328:2370.

  70. ABBASI J
    Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic.
    JAMA. 2022 Dec 15. doi: 10.1001/jama.2022.23241.

  71. LARKIN H
    Investigational RSV Vaccine Given During Pregnancy Protects Newborns.
    JAMA. 2022;328:2201.

  72. MARKS PW, Gruppuso PA, Adashi EY
    Urgent Need for Next-Generation COVID-19 Vaccines.
    JAMA. 2022 Dec 9. doi: 10.1001/jama.2022.22759.

    Novavax COVID-19 Vaccine Booster Authorized.
    JAMA. 2022;328:2101.

  74. MANMADHAN A, Ahuja T
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022;328:2164-2165.

  75. MACK CD, Anderson DJ, DiFiori J
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association-Reply.
    JAMA. 2022;328:2165.

    November 2022
    Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
    JAMA. 2022;328:2003.

  77. KUEHN BM
    Targeted Flu Vaccination Campaigns Needed for Certain Racial and Ethnic Groups.
    JAMA. 2022;328:2005.

  78. RUBIN R
    Vaccine Approved in Pregnancy to Protect Young Infants.
    JAMA. 2022;328:1898.

    WHO Backs Single Dose of Hepatitis A Vaccine in Some Cases.
    JAMA. 2022;328:1896.

    Studies Find Single Dose of HPV Vaccines May Be Effective.
    JAMA. 2022;328:1896.

  81. KUEHN BM
    Shifting Hepatitis A Epidemiology Requires Renewed Vaccination Efforts.
    JAMA. 2022;328:1800.

  82. KUEHN BM
    Single Monkeypox Vaccine Dose Provides Some Protection.
    JAMA. 2022;328:1801.

  83. KUEHN BM
    Second COVID-19 Booster Increases Protection for Nursing Home Patients.
    JAMA. 2022;328:1800-1801.

    October 2022
  84. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
    PubMed     Abstract available

  85. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
    Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    JAMA. 2022;328:1523-1533.
    PubMed     Abstract available

    Rotavirus Leads Global Diarrhea Hospitalizations Among Young Children.
    JAMA. 2022;328:1490.

    Progress on Replication-Defective Live Virus Vaccines.
    JAMA. 2022;328:1387.

  88. KUEHN BM
    Catch-up Vaccinations Needed for Some Adolescents.
    JAMA. 2022;328:1389-1390.

  89. ABBASI J
    White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
    JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.

    September 2022
  90. HAZRA A, Rusie L, Hedberg T, Schneider JA, et al
    Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine.
    JAMA. 2022 Sep 30. pii: 2797135. doi: 10.1001/jama.2022.18320.

  91. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
    Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
    PubMed     Abstract available

  92. TENFORDE MW, Link-Gelles R, Patel MM
    Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.

  93. LIN DY, Gu Y, Xu Y, Wheeler B, et al
    Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
    PubMed     Abstract available

  94. RIDGWAY JP, Tideman S, French T, Wright B, et al
    Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
    JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.

  95. RUBIN R
    The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
    JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.

    Backslide in Global Childhood Vaccinations.
    JAMA. 2022;328:1029.

    New Data on Heterologous COVID-19 Vaccine Combinations.
    JAMA. 2022;328:916-917.

    FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access.
    JAMA. 2022;328:819.

  99. CULLEN JP, Russ S, Russell HA
    Theater for Vaccine Hesitancy-Setting the Stage for Difficult Conversations.
    JAMA. 2022 Sep 2. pii: 2796160. doi: 10.1001/jama.2022.14864.

    August 2022
  100. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    PubMed     Abstract available

  101. RUBIN R
    Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
    JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.

  102. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    PubMed     Abstract available

  103. LARKIN HD
    New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
    JAMA. 2022;328:518.

  104. KUEHN BM
    More Effective Flu Vaccines Recommended for Older Adults.
    JAMA. 2022;328:519.

    July 2022
  105. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.

  106. LARKIN HD
    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.

  107. KUEHN BM
    Newer Poxvirus Vaccine Is Recommended.
    JAMA. 2022;328:123.

  108. RUBIN R
    COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.

  109. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.

    June 2022
  110. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.

  111. LARKIN HD
    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.

  112. LARKIN HD
    Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
    JAMA. 2022;327:2182.

  113. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.

  114. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.

  115. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.

  116. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.

  117. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.

    May 2022
  118. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.

  119. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.

  120. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.

  121. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    PubMed     Abstract available

  122. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.

  123. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.

  124. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.

  125. KUEHN BM
    Age Range Is Expanded for Universal Hepatitis B Vaccination.
    JAMA. 2022;327:1749.

  126. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.

  127. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.

  128. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.

    April 2022
  129. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.

  130. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.

  131. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.

  132. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.

  133. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.

  134. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.

  135. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.

  136. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.

  137. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    PubMed     Abstract available

  138. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.

    March 2022
  139. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed     Abstract available

  140. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.

  141. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    PubMed     Abstract available

  142. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    PubMed     Abstract available

  143. SLOMSKI A
    Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
    JAMA. 2022;327:1118.

  144. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.

  145. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.

  146. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.

  147. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.

    February 2022
  148. ABBASI J
    Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
    JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.

  149. KUEHN BM
    New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
    JAMA. 2022;327:614.

  150. KUEHN BM
    COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
    JAMA. 2022;327:614.

  151. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    PubMed     Abstract available

  152. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.

  153. ABBASI J
    Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    JAMA. 2022;327:517.

  154. KUEHN BM
    Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
    JAMA. 2022;327:518.

  155. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.

    January 2022
  156. SURAN M
    Coverage of COVID-19 Vaccine Counseling for Children and Youths.
    JAMA. 2022;327:313.

  157. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.

  158. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.

  159. OSTER ME, Shay DK, Su JR, Gee J, et al
    Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    JAMA. 2022;327:331-340.
    PubMed     Abstract available

  160. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.

  161. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.

  162. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.

  163. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.

  164. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    PubMed     Abstract available

  165. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.

  166. KUEHN BM
    Vaccine Development Is Charting a New Path in Malaria Control.
    JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.

  167. KUEHN BM
    Vaccine Passports Help Boost Lagging Vaccination Rates.
    JAMA. 2022;327:209.

  168. ADASHI EY, Cohen IG
    The Pandemic Preparedness Program: Reimagining Public Health.
    JAMA. 2022;327:219-220.

  169. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.

  170. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.

  171. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.

  172. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.

  173. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.

  174. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.

  175. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
    Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
    PubMed     Abstract available

  176. BORIO LL, Bright RA, Emanuel EJ
    A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.

    December 2021
  177. ABBASI J
    RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.

  178. Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA. 2021;326:2521-2522.

  179. SLOMSKI A
    More Pediatric Data for First Cell-Derived Influenza Vaccine.
    JAMA. 2021;326:2464.

  180. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.

  181. ABBASI J
    Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
    JAMA. 2021;326:2460-2462.

  182. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.

  183. DEL RIO C, Omer SB, Malani PN
    Winter of Omicron-The Evolving COVID-19 Pandemic.
    JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.

  184. KUEHN BM
    Vaccination Doesn't Eliminate Delta Variant Household Transmission.
    JAMA. 2021;326:2353.

  185. COHN AC, Mahon BE, Walensky RP
    One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
    JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.

  186. LEVY M, Recher M, Hubert H, Javouhey E, et al
    Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
    JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.

  187. ADAMS LE, Waterman S, Paz-Bailey G
    Vaccination for Dengue Prevention.
    JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.

  188. BATES TA, McBride SK, Winders B, Schoen D, et al
    Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.

  189. SURAN M
    Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
    JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.

  190. ABBASI J
    COVID-19 Vaccine Combination Was Superior in Real-world Study.
    JAMA. 2021;326:2250.

  191. WALTER K
    COVID-19 and Pregnancy.
    JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.

  192. Current Comment.
    JAMA. 2021;326:2217.

  193. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
    Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
    JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.

  194. ABBASI J
    Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
    JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.

  195. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
    US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
    JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.

    November 2021
  196. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.

  197. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.

  198. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.

  199. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.

  200. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.

  201. SFEIR MM, Snayd M
    Serologic Testing for Hepatitis B.
    JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.

  202. CHOR J, Davis AM, Rusiecki JM
    Cervical Cancer Screening Guideline for Individuals at Average Risk.
    JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.

  203. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.

  204. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.

  205. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.

  206. Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.

  207. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.

  208. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.

  209. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.

  210. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    PubMed     Abstract available

  211. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.

  212. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.

  213. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available

    October 2021
  214. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.

  215. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.

  216. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.

  217. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.

  218. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.

  219. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.

  220. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.

  221. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    PubMed     Abstract available

    September 2021
  222. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.

    Shots in Arms.
    JAMA. 2021;326:1151-1152.

    August 2021
  224. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.

  225. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.

  226. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.